Vaccine Breakthrough Published in Nature Communications Highlights Research of Startup VaxNewMo
Feb 21, 2019
BioGenerator-supported startup noted for its ‘promising process’ to more quickly and affordably bring vaccines to market
St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines faster with its patented technology. The company’s breakthrough research is currently featured in Nature Communications.